Government Pharmaceutical Organization

Africa CDC Director General Visits SK bioscience to Discuss Vaccine Localization in Africa

Retrieved on: 
Sunday, November 5, 2023
African, Health, Therapy, Public health, Vaccine, GPO, HIV, Malaria, Disease, AU, Research, R, Republic, Government Pharmaceutical Organization, MOU, CDC, Partnership, Korea Carbon Capture & Sequestration R&D Center, Infection, African Union, Pandemic, Hepatitis B, SK, African Center for Economic Transformation, Tuberculosis, Africa Centres for Disease Control and Prevention, Pharmaceutical industry

H.E Dr. Jean Kaseya, Director General of the African Centers for Disease Control and Prevention (Africa CDC), visited SK bioscience to discuss the vaccine localization program in the African continent.

Key Points: 
  • H.E Dr. Jean Kaseya, Director General of the African Centers for Disease Control and Prevention (Africa CDC), visited SK bioscience to discuss the vaccine localization program in the African continent.
  • SK bioscience introduced the 'Glocalization Project' which is transplanting R&D and manufacturing capabilities to countries that lack sufficient vaccine infrastructures.
  • SEONGNAM, South Korea, Nov. 5, 2023 /PRNewswire/ -- SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that H.E Dr. Jean Kaseya, Director General of Africa CDC visited SK bioscience headquarters on November 3 to discuss collaboration with the Partnerships for African Vaccine Manufacturing (PAVM).
  • Dr. Kaseya was appointed as the Director General of Africa CDC in February 2023.

The Executive Talk by ShareInvestor: Rojukiss International PCL (SET: KISS)

Retrieved on: 
Friday, November 4, 2022
Pillar, Infection, Beauty, Research, COVID-19, Growth, Sale, Government Pharmaceutical Organization, Nasal cavity, Institute, HPMC, Industry, Antibody, Executive, Faculty, KISS, Silpakorn University, Monoclonality, Neutralizing antibody, Human, PCL, Korea, GPO, Consumer, Chulalongkorn University, Volunteering, SET, HIB, Patient, Immunity, Communication, Pharmaceutical industry, Sales, Retail, Vaccine, Public relations, Medicine

Rojukiss International PCL Chief Executive Officer, Ms. Worrawan Chaikamnerd

Key Points: 
  • Rojukiss International PCL Chief Executive Officer, Ms. Worrawan Chaikamnerd
    1.
  • The priority is to grow and strengthen our core brand - the Rojukiss brand by enhancing the product innovation.
  • As a result, Rojukiss has continued to grow despite the challenging business environment amid the slow trending of Covid-19 pandemic.
  • On behalf of Rojukiss International Pcl, we will continue to develop products through innovations and with latest technologies under ethical business practices and good corporate governance.

AUDACIOUS Opens Medical Cannabis Clinic in Southeast Asia, Expanding Global Footprint into Thai Medical Cannabis Market

Retrieved on: 
Monday, March 21, 2022
Company, NR, Canadian Securities Exchange, Forward-looking statement, LAS, MSO, Multimedia, Patient, Compliance, Research, Government Pharmaceutical Organization, CSO, Medicine, GTH, View, Industry, Knowledge, CBD, Phrase, Solution, News, Cannabis, Golden Triangle, Partnership, Drug

Herbidus is among the first clinics in Asia that can prescribe cannabis for medical treatments in compliance with the law.

Key Points: 
  • Herbidus is among the first clinics in Asia that can prescribe cannabis for medical treatments in compliance with the law.
  • "Interest in medical cannabis is expanding rapidly in Thailand," said Terry Booth, Chief Executive Officer at AUDACIOUS.
  • "With the opening of the Herbidus Medical Center, we are looking forward to bringing AUDACIOUS' cannabis expertise and seasoned corporate leadership to the Thai cannabis market.
  • Added AUDACIOUS Chief Operating Officer Duke Fu: "We believe the nascent cannabis market in Asia offers thrilling new and massive addressable market for AUDACIOUS.

Icertis Raises Stakes for CLM Market with Launch of First Vertical Solutions

Retrieved on: 
Thursday, October 21, 2021
People, Contract, Infor, Commerce, IDC, Compliance, ERP, Efficiency, Technology, Microsoft, Government, Industry, Digital, IP, 1,000,000, SAP, Privacy, Organization, Health care, Adoption, Becton, Dickinson and Company headquarters, Policy, CLM, List of life sciences, Corporation, Product management, SLA, Risk, CPG, Forrester, Senior, Record, Maintenance, Company, Legal technology, Salesforce, Government Pharmaceutical Organization, Artificial intelligence, Solution, SOW, CRM, EL, MGI, ICI, Distribution, Yoy, Cognizant, Enterprise, AI, Risk management, Management, Online shopping, Health insurance, Medical device

The CLM solutions are designed to speed delivery by up to 30%, increasing performance and improving contract excellence.

Key Points: 
  • The CLM solutions are designed to speed delivery by up to 30%, increasing performance and improving contract excellence.
  • More information about Icertis vertical solutions can be found at www.icertis.com/vertical-solutions .
  • Icertis plans to release its second phase of vertical solutionsforHealthcare providers, Government, Pharmaceutical, and Retailin early 2022.
  • With unmatched technology and category-defining innovation, Icertis pushes the boundaries of what's possible with CLM.